Literature DB >> 25280023

The "mystery" of cutaneous sarcoidosis: facts and controversies.

G Tchernev1, J C Cardoso2, A A Chokoeva3, S B Verma4, C Tana5, J Ananiev6, M Gulubova6, S Philipov7, N Kanazawa8, P Nenoff9, T Lotti10, U Wollina11.   

Abstract

The reason why the cutaneous form of sarcoidosis is well known in the literature is because of its spectrum of manifestations granting it the fame of a Great Imitator. The mystery shrouding the pathogenesis of this rare cutaneous disease is still there (in spite of the fundamental progress of the various diagnostic methods in current day medicine). The production of the morphological substrate - the epithelioid cell granuloma - which is considered to be characteristic of skin sarcoidosis, could, however, also be the end result of a reaction to i) various specific infectious agents such as Leishmaniasis cutis, coccidioidomycosis, etc., ii) certain residual bacterial or other mycobacterial antigens which, at the moment of setting the diagnosis are - by definition - non-infectious but still immunogenic, as well as iii) different tumor antigens in lesional tissue or other location. Often, differentiating between sarcodiosis and a sarcoid-like reaction, based on the updated criteria for cutaneous sarcoidosis, is problematic to downright impossible. A future characterization of the genetic signature of the two conditions, as well as the implementation of additional mandatory panels for i) the identification of certain infectious or ii) non-infectious but immunogenic and iii) tumor antigens in the epithelioid cell granuloma (or in another location in the organism), could be a considerable contribution to the process of differentiating between the two above-mentioned conditions. This will create conditions for greater accuracy when setting the subsequent therapeutic approaches.

Entities:  

Mesh:

Year:  2014        PMID: 25280023     DOI: 10.1177/039463201402700302

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  8 in total

1.  Sarcoid-like reactions (SLRs) or autonomous sarcoidosis (AS)? Differentiation probably important?

Authors:  Georgi Tchernev; Anastasiya Atanasova Chokoeva; Uwe Wollina; Torello Lotti
Journal:  Wien Med Wochenschr       Date:  2015-10-06

2.  Case Study: Cardiac sarcoidosis resolved with Mycobacterium avium paratuberculosis antibiotics (MAP).

Authors:  Branko G Celler
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 3.  Sarcoidosis in Melanoma Patients: Case Report and Literature Review.

Authors:  Bryce D Beutler; Philip R Cohen
Journal:  Cancers (Basel)       Date:  2015-06-15       Impact factor: 6.639

4.  Immunocompromised Districts of Skin: A Case Series and a Literature Review.

Authors:  Aleksandra Vojvodic; Michael Tirant; Veronica di Nardo; Torello Lotti; Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2019-09-10

5.  Sarcoidosis: An Old but Always Challenging Disease.

Authors:  Claudio Tana
Journal:  Diagnostics (Basel)       Date:  2021-04-14

Review 6.  Clinical Features, Histopathology and Differential Diagnosis of Sarcoidosis.

Authors:  Claudio Tana; Iginio Donatiello; Alessandro Caputo; Marco Tana; Teresa Naccarelli; Cesare Mantini; Fabrizio Ricci; Andrea Ticinesi; Tiziana Meschi; Francesco Cipollone; Maria Adele Giamberardino
Journal:  Cells       Date:  2021-12-26       Impact factor: 6.600

Review 7.  Clinical Features and Diagnosis of Cardiac Sarcoidosis.

Authors:  Claudio Tana; Cesare Mantini; Iginio Donatiello; Luciano Mucci; Marco Tana; Fabrizio Ricci; Francesco Cipollone; Maria Adele Giamberardino
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

8.  Sarcoidosis in A. C. Milan (1899)?

Authors:  Georgi Tchernev; Torello Lotti; Uwe Wollina; José Carlos Cardoso; Lyubomira Viktor Popova; Georgi Konstantinov Maximov; Ilia Lozev; Ivan Terziev
Journal:  Open Access Maced J Med Sci       Date:  2018-01-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.